1003-3734
2014 Issue 7
bian zhe tui jian
guo chao wei ;
guo chao wei ;
..............page:724
2014 nian zhong mei yao wu lin chuang yan jiu yu zhuan hua yi xue qian yan jin zhan guo ji jiao liu lun tan ji gao ji yan xiu ban zai jing cheng gong ju ban
wang zuo ; zuo ke ;
wang zuo ; zuo ke ;
..............page:726
..............page:728-730
WINDOW OF NEW DRUGS
ben kan ;
ben kan ;
..............page:731-732
Overview of the latest progress of the global drug research in key therapeutic areas
CHEN Ling;ZOU Xu;HUANG Wen-long;China Pharmaceutical University;
CHEN Ling;ZOU Xu;HUANG Wen-long;China Pharmaceutical University;
..............page:733-752
..............page:752
Individual operation: structure modification of natural products
GUO Ying;GUO Zong-ru;Institute of Materia Medica;Chinese Academy of Medical Sciences;Peking Union Medical College;
GUO Ying;GUO Zong-ru;Institute of Materia Medica;Chinese Academy of Medical Sciences;Peking Union Medical College;
..............page:753-758+780
Requirements of technologies and methods for the quality control of drug polymorphism
L Yang;ZHANG Li;YANG Shi-ying;DU Guan-hua;CHEN Gui-liang;ZHANG Qi-ming;Beijing Key Laboratory of Polymorphic Drugs;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Drug Crystallographic Committee of Chinese Crystallographic Society;Chinese Pharmacological Society;Shanghai Institute for Food and Drug Control;National Institutes for Food and Drug Control;
L Yang;ZHANG Li;YANG Shi-ying;DU Guan-hua;CHEN Gui-liang;ZHANG Qi-ming;Beijing Key Laboratory of Polymorphic Drugs;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Drug Crystallographic Committee of Chinese Crystallographic Society;Chinese Pharmacological Society;Shanghai Institute for Food and Drug Control;National Institutes for Food and Drug Control;
..............page:759-763
Current situation of international and national research of orphan drugs
CHEN Miao;FENG Wen-hua;Insititute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;
CHEN Miao;FENG Wen-hua;Insititute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;
..............page:764-768
Method validation of flow cytometric analysis of micronucleus in rodent peripheral blood
ZHOU Chang-hui;ZHANG Ming;WANG Zheng;TU Hong-gang;HUANG Fang-hua;WANG Qing-li;CHANG Yan;National Shanghai Center for New Drug Safety Evaluation & Research;China State Institute of Pharmaceutical Industry;Center for Drug Evaluation;China Food and Drug Administration;
ZHOU Chang-hui;ZHANG Ming;WANG Zheng;TU Hong-gang;HUANG Fang-hua;WANG Qing-li;CHANG Yan;National Shanghai Center for New Drug Safety Evaluation & Research;China State Institute of Pharmaceutical Industry;Center for Drug Evaluation;China Food and Drug Administration;
..............page:769-774
Establishment of an HPLC-DAD method to quantify a new cholinesterase inhibitor J39136 in rat plasma and tissues and study on its tissue distribution
FENG Zhang-ying;SONG Jun-ke;HUANG Chao;LIU Ai-lin;DU Guan-hua;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Fourth Hospital of Hebei Medical University;Key Laboratory of Target Research and Drug Screening;
FENG Zhang-ying;SONG Jun-ke;HUANG Chao;LIU Ai-lin;DU Guan-hua;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Fourth Hospital of Hebei Medical University;Key Laboratory of Target Research and Drug Screening;
..............page:775-780
Establishment and application of a high-throughput screening assay for Cdk5/p35 inhibitors
YANG Ran-yao;FANG Jian-song;ZHOU Dan;LIU Ai-lin;DU Guan-hua;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Beijing Key Laboratory of Drug Target and Screening Research;State Key Laboratory of Natural Active Substance and Function;
YANG Ran-yao;FANG Jian-song;ZHOU Dan;LIU Ai-lin;DU Guan-hua;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Beijing Key Laboratory of Drug Target and Screening Research;State Key Laboratory of Natural Active Substance and Function;
..............page:781-786
..............page:786
Advances in expressing biopharmaceuticals in rice endosperm
DUAN Yong-bo;ZHAO Feng-lan;NI Da-hu;ZHANG Xu;XUE Jian-ping;Key Laboratory of Resource Plant Biology of Anhui Province;College of Life Sciences;Huaibei Normal University;Key Laboratory of Rice Genetics Breeding of Anhui Province;Rice Research Institute;Anhui Academy of Agricultural Sciences;
DUAN Yong-bo;ZHAO Feng-lan;NI Da-hu;ZHANG Xu;XUE Jian-ping;Key Laboratory of Resource Plant Biology of Anhui Province;College of Life Sciences;Huaibei Normal University;Key Laboratory of Rice Genetics Breeding of Anhui Province;Rice Research Institute;Anhui Academy of Agricultural Sciences;
..............page:787-792
Progress in the study of PARP-1 inhibitors
ZHANG Teng;WANG Cui-ling;ZHANG Ning;LIU Jian-li;Key Laboratory of Resource Biology and Biotechnology in Western China;Ministry of Education;School of Life Science;Northwest University;
ZHANG Teng;WANG Cui-ling;ZHANG Ning;LIU Jian-li;Key Laboratory of Resource Biology and Biotechnology in Western China;Ministry of Education;School of Life Science;Northwest University;
..............page:793-801
Progress in research of selective S1P1 receptor ligands
LI Zhong-tang;CONG Yu-wen;ZHANG Qing-lin;YANG Ri-fang;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;Institute of Radiation Medicine;Academy of Military Medical Sciences;
LI Zhong-tang;CONG Yu-wen;ZHANG Qing-lin;YANG Ri-fang;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;Institute of Radiation Medicine;Academy of Military Medical Sciences;
..............page:802-810+818
Adjunctive treatment of risperidone-induced hyperprolactinemia with aripiprazole: a randomized,double-blind,placebo-controlled study
CHEN Jing-xu;ZHANG Rong-zhen;LI Wei;LIU Yan-hong;JIANG Li-yan;BIAN Qing-tao;WANG Shao-li;YANG Fu-de;Beijing Huilongguan Hospital;
CHEN Jing-xu;ZHANG Rong-zhen;LI Wei;LIU Yan-hong;JIANG Li-yan;BIAN Qing-tao;WANG Shao-li;YANG Fu-de;Beijing Huilongguan Hospital;
..............page:811-814
Clinical observation of pegylated recombinant human granulocyte colony-stimulating factor in preventing chemotherapy-induced neutropenia
ZHANG Ming;LAN Hai-tao;CHEN Lin;Department of Oncology;Sichuan Provincial People’s Hospital;
ZHANG Ming;LAN Hai-tao;CHEN Lin;Department of Oncology;Sichuan Provincial People’s Hospital;
..............page:815-818
Simultaneous determination of two components of Xin Shao extract in rat plasma by UPLC-MS and their pharmacokinetics and absolute bioavailability
ZHENG Lin;MU Jing-li;TANG Li;LIU Yue;WANG Ai-min;LAN Yan-yu;School of Pharmacy;Guiyang Medical College;Provincial Key Laboratory of Pharmaceutics in Guizhou Province;Engineering Research Center for the Development and Application of Ethnic Medicines and TCM;Ministry of Education;
ZHENG Lin;MU Jing-li;TANG Li;LIU Yue;WANG Ai-min;LAN Yan-yu;School of Pharmacy;Guiyang Medical College;Provincial Key Laboratory of Pharmaceutics in Guizhou Province;Engineering Research Center for the Development and Application of Ethnic Medicines and TCM;Ministry of Education;
..............page:819-823
Study on preparation and sustained-release of chitosan thermosensitive hydrogel by central composite design and response surface methodology
LI Xiao-juan;GUO Ya-ke;HAN Bo;CHEN Wen;School of Pharmacy;Shihezi University;
LI Xiao-juan;GUO Ya-ke;HAN Bo;CHEN Wen;School of Pharmacy;Shihezi University;
..............page:824-828
Study on quality control of alliin /allinase enteric-coated tablets
ZHANG Hai-bo;LI Xin-xia;ZHAO Dong-sheng;SONG Bai-ling;XIE Li-ting;CHEN Jian;Xinjiang Medical University;Xinjiang Bill Brother Bio-tech Co.;Ltd.;Xinjiang Ailexin Pharmaceutical Co.;Ltd.;Kuche People’s Hospital;
ZHANG Hai-bo;LI Xin-xia;ZHAO Dong-sheng;SONG Bai-ling;XIE Li-ting;CHEN Jian;Xinjiang Medical University;Xinjiang Bill Brother Bio-tech Co.;Ltd.;Xinjiang Ailexin Pharmaceutical Co.;Ltd.;Kuche People’s Hospital;
..............page:829-832+838
A comparative study on effects of Ginkgo biloba extract and Ginkgo flavonoid on Lipid Metabolism in SD Rats with hyperlipidemia
CHEN Mei-xia;SU Jie;ZHANG Yue-li;CHEN Su-hong;LV Gui-yuan;Zhejiang Chinese Medical University;Wenzhou Medical University;
CHEN Mei-xia;SU Jie;ZHANG Yue-li;CHEN Su-hong;LV Gui-yuan;Zhejiang Chinese Medical University;Wenzhou Medical University;
..............page:833-838
Determination of ulipristal acetate and its related substances by HPLC
SHI Jin-xiao;ZHU Feng-yan;ZOU Qiao-gen;SUN Li-li;WEI Ping;College of Biotechnology and Pharmaceutical Engineer;Nanjing University of Technology;Nanjing Healthnice Medical Technology Co.;Ltd.;
SHI Jin-xiao;ZHU Feng-yan;ZOU Qiao-gen;SUN Li-li;WEI Ping;College of Biotechnology and Pharmaceutical Engineer;Nanjing University of Technology;Nanjing Healthnice Medical Technology Co.;Ltd.;
..............page:839-842+852
The incidence of digestive system adverse events of tripterygiumwilfordiihook. f: a systematic review and meta-analysis
SUN Feng;YANG Xing-hua;MA Dong-mei;ZHAN Si-yan;Department of Epidemiology and Biostatistics;School of Public Health;Peking University;Department of Epidemiology and Biostatistics;School of Public Health;Capital Medical University;
SUN Feng;YANG Xing-hua;MA Dong-mei;ZHAN Si-yan;Department of Epidemiology and Biostatistics;School of Public Health;Peking University;Department of Epidemiology and Biostatistics;School of Public Health;Capital Medical University;
..............page:843-852
..............page:853